Form 4 holding
CHIEF EXECUTIVE OFFICER, Director
Compass Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 6,603,336
- Estimated value
- $43,053,750
- Report date
- 08 Feb 2026
- Price
- $6.52
- Ownership
- Direct
Thomas J. Schuetz - CHIEF EXECUTIVE OFFICER, Director at Compass Therapeutics, Inc.
Issuer-level insider activity
- Role
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- CMPX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Thomas J. Schuetz since 05 Sep 2025
Reported holdings for Thomas J. Schuetz in Compass Therapeutics, Inc.
Form 4 holding
CHIEF EXECUTIVE OFFICER, Director
Compass Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 2,000,000
- Estimated value
- Report date
- 02 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Thomas J. Schuetz in Compass Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.